MedTrace Logo

Strength, Aging, and Memory in Prostate Cancer

NCT04852224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-09-19

No results posted yet for this study

Summary

The objective of this study is to compare changes in neurocognitive function across a 12-month period between three groups: (1) men treated with androgen deprivation therapy (ADT) for prostate cancer (PCa); (2) men under active surveillance for PCa; and (3) men without a history of cancer.

Conditions

Sponsors & Collaborators

  • American College of Sports Medicine

    collaborator OTHER

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Diane Ehlers, PhD · University of Nebraska

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2023-04-11
Completion
2023-04-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04852224 on ClinicalTrials.gov